National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, 20892, United States
NCT Number: NCT00001549
The purpose of this study is to improve understanding of neurological conditions. Patients participating in this study will continue receiving medical care, routine laboratory tests, and diagnostics tests (X-rays, CT-scans, and nuclear imaging), from their primary care physician. Doctors at the NIH plan to follow these patients and offer advice and assistance to their primary care physicians.
Looking for future studies?
Notify MeAll sexes
Observational
Bethesda, Maryland, 20892, United States
The objective of this protocol is to provide diagnosis and follow Experimental Therapeutics Branch (ETB) patients not currently entered on another research protocol. No investigational treatments will be administered on this protocol, and the NIH physicians will be playing largely a consultative role to the patient's primary physician.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients may be included on this protocol if they have an identifiable neurological disorder or represent a diagnostic puzzle. These disorders would include patients with Parkinson's disease, Alzheimer's disease, multiple system atrophy, progressive supranuclear palsy, restless legs syndrome, other cognitive and movement disorders, and diagnostic puzzles.
Patients 18-90 years of age, inclusive, are eligible.
National Institute of Neurological Disorders and Stroke (NINDS)
Nih
Diagnosis and Natural History Protocol for Patients With Neurological Conditions
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02761707
Alzheimer Disease, Alzheimer's Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT02860338
Alzheimer Disease, Alzheimer's Disease
View Trial DetailsNCT04396873
ALS, Alzheimer Disease
Bethesda, Maryland, United States
View Trial DetailsNCT00654563
Alzheimer Disease, Alzheimer's Disease
Los Angeles, California, United States
View Trial Details